4D Molecular Therap 
Welcome,         Profile    Billing    Logout  
 0 Products   0 Diseases  0 Products   0 Trials   0 News 
7 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
4D-710 / 4D Molecular Therap
AEROW, NCT05248230: 4D-710 in Adult Patients with Cystic Fibrosis

Recruiting
1/2
40
US
4D-710
4D Molecular Therapeutics
Cystic Fibrosis Lung
12/26
01/30
4D-125 / 4D Molecular Therap
NCT04517149: 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

Active, not recruiting
1/2
21
US
4D-125 IVT Injection, Observational
4D Molecular Therapeutics
X-Linked Retinitis Pigmentosa
06/26
05/29
4D-110 / 4D Molecular Therap, Roche
NCT04483440: Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia

Active, not recruiting
1
13
US
4D-110
4D Molecular Therapeutics
Choroideremia
06/24
06/27
4D-150 / 4D Molecular Therap
NCT05930561: 4D-150 in Patients With Diabetic Macular Edema

Recruiting
2
72
US
4D-150 IVT, Aflibercept IVT, Eylea
4D Molecular Therapeutics
Diabetic Macular Edema, Diabetic Retinopathy
02/28
07/28
PRISM, NCT05197270: 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

Recruiting
1/2
215
US
4D-150 IVT, Aflibercept IVT
4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
11/25
11/26
4D-310 / 4D Molecular Therap
NCT04519749: An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease

Active, not recruiting
1/2
18
US
4D-310
4D Molecular Therapeutics
Fabry Disease
01/26
06/30
NCT05629559: 4D-310 in Adults With Fabry Disease and Cardiac Involvement

Active, not recruiting
1/2
18
RoW
4D-310
4D Molecular Therapeutics
Fabry Disease
01/26
01/30
4D-725 / 4D Molecular Therap
No trials found
4D-175 / 4D Molecular Therap
No trials found

Download Options